Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,094.00 JPY | -0.85% | -1.89% | +12.32% |
09-06 | Japan Tobacco Unit JT International Thailand Gains Specified Subsidiary Status | MT |
08-26 | Vector Purchase to Pressure Japan Tobacco's Financials, S&P Says | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,176B | 2,093B | 2,325B | 2,658B | 2,841B | |||||
Total Revenues | 2,176B | 2,093B | 2,325B | 2,658B | 2,841B | |||||
Cost of Goods Sold, Total | 942B | 898B | 957B | 1,091B | 1,226B | |||||
Gross Profit | 1,233B | 1,195B | 1,368B | 1,567B | 1,615B | |||||
Selling General & Admin Expenses, Total | 662B | 600B | 715B | 756B | 801B | |||||
R&D Expenses | 64.08B | 60.85B | 65.02B | 70.81B | 75.1B | |||||
Depreciation & Amortization - (IS) | 106B | 104B | 109B | 114B | 105B | |||||
Other Operating Expenses | -19.6B | -8.27B | -7.4B | -11.36B | -11.08B | |||||
Other Operating Expenses, Total | 812B | 756B | 881B | 930B | 970B | |||||
Operating Income | 421B | 439B | 487B | 637B | 645B | |||||
Interest Expense, Total | -27.56B | -22.53B | -23.05B | -27.02B | -28.49B | |||||
Interest And Investment Income | 7.94B | 7.32B | 13.37B | 26.54B | 42.82B | |||||
Net Interest Expenses | -19.61B | -15.22B | -9.68B | -485M | 14.32B | |||||
Income (Loss) On Equity Invest. | 5.01B | 4.04B | 4B | 8.01B | 8.33B | |||||
Currency Exchange Gains (Loss) | -13.3B | -35.81B | -15.56B | -35.08B | -51.88B | |||||
Other Non Operating Income (Expenses) | -4.21B | 4.21B | -1.39B | -24.56B | -13.25B | |||||
EBT, Excl. Unusual Items | 389B | 396B | 464B | 585B | 603B | |||||
Restructuring Charges | - | 1.69B | - | - | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 76.12B | 34.62B | 8.22B | 8.9B | 18.95B | |||||
Asset Writedown | - | -12.24B | - | - | - | |||||
EBT, Incl. Unusual Items | 465B | 420B | 472B | 593B | 622B | |||||
Income Tax Expense | 104B | 108B | 132B | 149B | 136B | |||||
Earnings From Continuing Operations | 362B | 312B | 340B | 444B | 485B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 362B | 312B | 340B | 444B | 485B | |||||
Minority Interest | -13.43B | -1.78B | -1.69B | -1.46B | -3.02B | |||||
Net Income - (IS) | 348B | 310B | 338B | 443B | 482B | |||||
Net Income to Common Incl Extra Items | 348B | 310B | 338B | 443B | 482B | |||||
Net Income to Common Excl. Extra Items | 348B | 310B | 338B | 443B | 482B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 195.97 | 174.88 | 190.76 | 249.45 | 271.69 | |||||
Basic EPS - Continuing Operations | 195.97 | 174.88 | 190.76 | 249.45 | 271.69 | |||||
Basic Weighted Average Shares Outstanding | 1.78B | 1.77B | 1.77B | 1.77B | 1.78B | |||||
Net EPS - Diluted | 195.87 | 174.8 | 190.68 | 249.36 | 271.63 | |||||
Diluted EPS - Continuing Operations | 195.87 | 174.8 | 190.68 | 249.36 | 271.63 | |||||
Diluted Weighted Average Shares Outstanding | 1.78B | 1.77B | 1.78B | 1.78B | 1.78B | |||||
Normalized Basic EPS | 129.31 | 138.5 | 162.54 | 205.03 | 210.48 | |||||
Normalized Diluted EPS | 129.25 | 138.44 | 162.47 | 204.96 | 210.43 | |||||
Dividend Per Share | 154 | 154 | 140 | 188 | 194 | |||||
Payout Ratio | 77.79 | 88.04 | 74.43 | 60.12 | 76.16 | |||||
American Depositary Receipts Ratio (ADR) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 605B | 607B | 674B | 836B | 825B | |||||
EBITA | 421B | 505B | 487B | 637B | 645B | |||||
EBIT | 421B | 439B | 487B | 637B | 645B | |||||
EBITDAR | - | 616B | - | - | - | |||||
Effective Tax Rate - (Ratio) | 22.27 | 25.72 | 27.99 | 25.15 | 21.93 | |||||
Total Current Taxes | - | 111B | - | - | - | |||||
Total Deferred Taxes | - | -3.11B | - | - | - | |||||
Normalized Net Income | 230B | 246B | 288B | 364B | 374B | |||||
Interest on Long-Term Debt | - | 1.46B | - | - | - | |||||
Non-Cash Pension Expense | -1.4B | 5.22B | 3.95B | 3.88B | 7.8B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 136B | 119B | 138B | 154B | 180B | |||||
Selling and Marketing Expenses | 191B | 177B | 205B | 233B | 259B | |||||
Research And Development Expense From Footnotes | 64.08B | 60.85B | 65.02B | 70.81B | 75.1B | |||||
Net Rental Expense, Total | - | 9.17B | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | 1.61B | - | - | - | |||||
Imputed Operating Lease Depreciation | - | 7.56B | - | - | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | 593M | - | - | - | |||||
Total Stock-Based Compensation | - | 593M | - | - | - |